Objective: To determine the safety of apnea testing. Design: Prospecti
ve, consecutive study. Setting: Inner-city trauma center. Patients: A
total of 70 apnea tests were performed on 61 comatose patients as part
of the determination of brain death. Results: Only 43 examinations (6
1%) were well tolerated. During 27 examinations (39%) patients either
developed marked hypotension (greater than or equal to 15% drop in mea
n arterial pressure) (n = 23) or required prophylactic vasopressor man
ipulation (n = 4). Of the 27 examinations in which hypotension develop
ed, 14 were aborted, two were tolerated despite marked hypotension, fo
ur were tolerated after administration of prophylactic epinephrine (n
= 1) or dopamine hydrochloride (n = 3), and seven were successfully co
mpleted after increases in the rate of dopamine infusion during the te
st. Conclusions: Hypotension can pose a significant risk to patients u
ndergoing apnea testing. Constant monitoring of vital signs throughout
the test is essential to its safe completion.